Project Grant HT94252410315
Award Date 6/1/24
Completion Date 5/31/26
Dollars Obligated $473K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
- The U.S. Defense Health Agency awarded a $1,562,257 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. This grant, awarded on May 1, 2025, supports research to investigate the therapeutic potential of targeting de novo pyrimidine synthesis to treat ovarian cancer. The research will be conducted in collaboration with a sub-awardee, the University of South Florida, whose role is to provide advanced statistical analysis and...
- This $472,498 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at The Ohio State University to target the UPP1-mediated pyrimidine salvage pathway to prevent ovarian cancer recurrence. The research aims to develop innovative approaches to disease prevention, diagnosis, and treatment for conditions relevant to military personnel and the broader public. This 2-year project,...
- The Ohio State University received a $156,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The two-year award beginning in June 2021 will support research on Fatty Acid Binding Protein-5 as a novel therapeutic target against aggressive lung cancer. Through this funding, The Ohio State University researchers will investigate medical solutions for lung cancer, advancing the Military Medical Research...
- This Project Grant award for $1,574,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. The award is for a research project titled "SLIT2 AS A NOVEL APPROACH FOR TARGETING METASTATIC BREAST CANCER" with a performance period from Jun 15, 2025 to Jun 14, 2028. The research aims to investigate innovative medical solutions for addressing breast cancer metastasis, a critical health challenge...
- The U.S. Defense Health Agency awarded a $826,875 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Novel Roles of SLIT2 in Enhancing Antitumor Immunity in Small Cell Lung Cancer." This 3-year grant, with a performance period from June 15, 2025 to June 14, 2028, will support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public by...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $551,250.00 to The Ohio State University to support research on PPP2R1B IN DEDIFFERENTIATED LIPOSARCOMA. The project will be performed in Columbus, OH and run from Sep 30, 2023 through Sep 29, 2026. The Ohio State University has a history of conducting biomedical research and providing clinical trial coordination services to federal agencies like the National...
- The Department of the Army Medical Command awarded a $3.876 million Project Grant to The Ohio State University Office of Sponsored Programs on August 1, 2022 under the Military Medical Research and Development program (CFDA 12.420). The four-year project will evaluate exosomal proteins as novel biomarkers for the early detection of endometrial cancer. The Ohio State University will lead the research effort to identify and validate exosomal protein biomarkers that could transform care for service...
- The Department of the Army Medical Command awarded a $3,874,682 Project Grant to The Ohio State University Office of Sponsored Programs under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the mechanisms of metastasis suppression and develop translational applications in thyroid cancer. As part of the Military Medical Research and Development program's goal to transform military and public health through...
- This federal Project Grant award of $1,251,451 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) aims to support research on metastatic progression in medullary thyroid cancer. The award period runs from July 1, 2023 to June 30, 2027 and will be carried out by the prime awardee, The Ohio State University (OSU). Under the grant, OSU will conduct genomic sequencing studies and organoid/metastasis-on-a-chip studies to investigate...
- The federal Project Grant award of $1,225,245.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research initiative titled "CARDIOVASCULAR RISK PROFILING OF DEPLOYMENT-RELATED RESPIRATORY DISEASE: A TRANSLATIONAL APPROACH" at The Ohio State University. The research project aims to investigate cardiovascular risk factors associated with deployment-related respiratory diseases, with the goal of developing...